EBLN3P and osteosarcoma: Recent studies have demonstrated that lncRNAs are crucial regulators of tumor growth and invasion; they have reported that LNC EBLN3P can function as an oncogene in osteosarcoma and lung adenocarcinoma, and the inhibition of EBLN3P can be used in the treatment of cancer [14,15].